Not exactly. Though both focus on GLP-1 receptors, Tirz also activates GIP receptors, rendering it a dual agonist. This broader mechanism is thought to improve its results on insulin sensitivity and appetite signaling in research products. El reto farmacológico de esta clase de moléculas es el stability entre las tres https://peptisell.com/product/nad-plus